SDGR
Schrodinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$29.02
−4.03%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$29.32
From 52W high−4.03%
Volume5.14M
Market cap$2.17B
P/E (TTM)—
P/S (TTM)8.4x
Div yield—
Key dataSep 18, 2026
Open
$29.32
From 52W high
−4.03%
Volume
5.14M
Market cap
$2.17B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−40.7x
P/E (TTM)
—
RSI (14)
77.5
MomentumView details →
1D Return
−4.03%
YTD Return
+62.58%
SummaryUpdated Jun 1, 2026
Schrödinger, Inc. (NASDAQ:SDGR) is a computational platform company founded in 1990 and headquartered in New York, New York. The company went public in February 2020 and operates at the intersection of physics-based computational methods and drug discovery. Schrödinger has evolved from a software company serving the pharmaceutical industry into a dual-business model enterprise that both licenses its computational platform to external customers and develops its own proprietary drug candidates. The company serves biopharmaceutical companies, industrial firms, academic institutions, and government laboratories worldwide.
Similar companies
Latest newsMore news →
Schrödinger, Inc. granted restricted stock units covering 2,243 shares of its common stock to three newly hired employees on September 13, 2026, under its 2021 Inducement Equity Incentive Plan.3d agoSchrodinger (SDGR) shares jumped 12.1% in the prior session on above-average trading volume.4d agoSchrödinger, Inc. granted restricted stock units covering 3,315 shares of common stock to two newly hired employees on August 12, 2026, as inducement grants under its 2021 Inducement Equity Incentive Plan.37d ago